Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification.
about
J-wave syndromes: Brugada and early repolarization syndromesT wave alternans does not assess arrhythmic risk in patients with Brugada syndrome.Variable electrocardiographic effects of short-term quinidine sulfate administration in Brugada syndrome.Relationship between dominant prolongation of the filtered QRS duration in the right precordial leads and clinical characteristics in Brugada syndrome.Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis.Brugada disease: chronology of discovery and paternity. Preliminary observations and historical aspectsApproach to the asymptomatic patients with Brugada syndrome.Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan.Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients.Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndromeMicrovolt T-wave alternans in short QT syndrome.Electrocardiographic methods for diagnosis and risk stratification in the Brugada syndromeUtility of T-wave alternans during night time as a predictor for ventricular fibrillation in patients with Brugada syndrome.Prevalence of Atrial Fibrillation in Patients with Brugada Syndrome in Taiwan.Usefulness of patient's history and non-invasive electrocardiographic parameters in prediction of ajmaline test results in patients with suspected Brugada syndromeBrugada syndrome: current clinical aspects and risk stratification.Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease.Diagnostic dilemmas: overlapping features of brugada syndrome and arrhythmogenic right ventricular cardiomyopathyBrugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.T wave alternans and ventricular tachyarrhythmia risk stratification: a review.Relationship Between Arrhythmogenic Right Ventricular Cardiomyopathy and Brugada Syndrome: New Insights From Molecular Biology and Clinical Implications.Dysfunction of the Voltage-Gated K+ Channel β2 Subunit in a Familial Case of Brugada Syndrome.Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada SyndromeEarly repolarization patterns and the role of additional proarrhythmic triggers.Reduced Penetrance and Variable Expression of SCN5A Mutations and the Importance of Co-inherited Genetic Variants: Case Report and Review of the Literature.Outcomes of Brugada Syndrome Patients with Coronary Artery Vasospasm.Murine Electrophysiological Models of Cardiac Arrhythmogenesis.In vivo studies of Scn5a+/- mice modeling Brugada syndrome demonstrate both conduction and repolarization abnormalities.Brugada syndrome: Controversies in Risk stratification and Management.Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient.Changes in follow-up ECG and signal-averaged ECG in patients with arrhythmogenic right ventricular cardiomyopathy.Wolff-Parkinson-White syndrome concomitant with asymptomatic Brugada syndrome.Temporal variation and morphologic characteristics of J-waves in patients with early repolarisation syndrome.Atrial electrical abnormality in patients with Brugada syndrome assessed by signal-averaged electrocardiography.Risk stratification in patients with Brugada syndrome: analysis of daily fluctuations in 12-lead electrocardiogram (ECG) and signal-averaged electrocardiogram (SAECG).Unsuccessful internal defibrillation in Brugada syndrome: focus on refractoriness and ventricular fibrillation cycle length.Signal-averaged electrocardiography: Past, present, and future.HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
P2860
Q26859366-D71EBE39-1F6A-4AA5-B9B2-CC6ED36193C1Q33151283-19DE836E-0485-47D0-83F6-E9E1E5306A22Q33152630-C7434F8A-1570-45BC-97B6-B726B6C69472Q33153461-D7C756F4-F6A5-425A-855A-E19E83989B28Q33154041-E16144FB-A53E-41E2-A5E8-4687E5DFD804Q33154219-55F8C893-088F-44DA-A30B-E09712D18A94Q33155183-47C99479-4A06-40DF-8CEF-B21AF9FEDC5BQ33155552-2B0BF1B5-1B10-403F-B8E7-737E99BED3C6Q33155780-AF45C6DC-FA05-450F-AEB2-9D890E95AF20Q33158008-7A5521E6-3F95-410C-9B38-F5D5172040DDQ33161656-83FC04A6-41A0-4157-8779-324A2BCAB162Q33165610-1B91E45A-6610-4791-8FE4-F23B3ED681CFQ33165751-9C8FF731-0037-4844-9174-C34B15A3FBB1Q33167104-0CB0C719-0356-4CAF-B50E-825CA836BF72Q34466700-FAE6095B-5E00-4F9F-B3B5-D104D89C0CD7Q34776479-BDCE38B5-A261-473E-B9CD-170B10C0EFC7Q35831609-ACA4EBCD-928C-456D-A177-847DDD779297Q35982138-926A6CDF-F22D-485F-A1D4-2CE8F83D0CC5Q36534132-1ECC3AD3-397E-4D16-9036-031363051C15Q36582218-E69B4AFE-DF85-4158-9D4D-940CF4860E8DQ36709335-E64D29A9-C186-4349-A265-D8A199D7F3DDQ37076110-BC34E3B4-9281-425D-AA72-1F90DA8FC32CQ37194514-6558A4FA-5A03-4ED1-8D8B-D7FD26C3E96BQ38070389-6B2E1894-ABA0-430F-8871-7D561BAE8BC2Q38221847-37D8C210-45DD-412C-BC74-D761C92F6A92Q39019318-5783BD0B-C51E-4712-8F19-38A879117940Q39038606-68E4A4D7-50EE-4FC8-B568-7ACDEB0412D6Q41909270-91A2FFEC-E260-4AC4-8258-4E855B0B6A4FQ42431740-B3A079A9-EDC5-41B9-B6FD-223E454F0902Q44557430-0BC8A3C2-9150-4985-841C-686B8B9CBDA6Q44712988-4C422BF6-B61E-4B39-88AE-BF673F59B36CQ44726476-C6EBA904-14D1-4D85-A35B-CB4921ADEA6FQ45266605-11E700FC-3BE9-4C9B-B9E6-11B65FA82307Q49646881-7CE8F981-CA4E-4B5C-9705-B5897A40A773Q51165138-A52D21BF-A8A3-40BD-BF8A-C655EAFA1539Q51507885-3918F9E2-8133-4315-8A48-73D5205D8318Q55359580-7D03C8E6-AB97-4A2A-8C53-DA9F421D881DQ58010282-AF9ABCD5-EE2E-4D48-85A8-32C9BC0BDD37
P2860
Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Assessment of noninvasive mark ...... ight into risk stratification.
@ast
Assessment of noninvasive mark ...... ight into risk stratification.
@en
type
label
Assessment of noninvasive mark ...... ight into risk stratification.
@ast
Assessment of noninvasive mark ...... ight into risk stratification.
@en
prefLabel
Assessment of noninvasive mark ...... ight into risk stratification.
@ast
Assessment of noninvasive mark ...... ight into risk stratification.
@en
P2093
P1476
Assessment of noninvasive mark ...... ight into risk stratification.
@en
P2093
Sakurada H
P304
P356
10.1016/S0735-1097(01)01197-4
P407
P577
2001-05-01T00:00:00Z